Martinez-Martin P - Search Results

1

Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS).

Martinez-Martin P, Catalan MJ, Benito-Leon J, Moreno AO, Zamarbide I, Cubo E, van Blercon N, Arillo VC, Pondal M, Linazasoro G, Alonso F, Ruiz PG, Frades B. Martinez-Martin P, et al. Qual Life Res. 2006 May;15(4):597-606. doi: 10.1007/s11136-005-4181-0. Qual Life Res. 2006. PMID: 16688493

2

An introduction to the concept of "quality of life in Parkinson's disease".

Martínez-Martín P. Martínez-Martín P. J Neurol. 1998 May;245 Suppl 1:S2-6. doi: 10.1007/pl00007733. J Neurol. 1998. PMID: 9617714

3

Quality of life in patients with Parkinson's disease who transfer from standard levodopa to Sinemet CR: the STAR Study. The STAR Multicenter Study Group.

Grandas F, Martínez-Martín P, Linazasoro G. Grandas F, et al. J Neurol. 1998 May;245 Suppl 1:S31-3. doi: 10.1007/pl00007736. J Neurol. 1998. PMID: 9617721 Clinical Trial.

4

Controlled release levodopa in Parkinson's disease: influence of selection criteria and conversion recommendations in the clinical outcome of 450 patients. STAR Study Group.

Linazasoro G, Grandas F, Martínez Martín P, Bravo JL. Linazasoro G, et al. Clin Neuropharmacol. 1999 Mar-Apr;22(2):74-9. Clin Neuropharmacol. 1999. PMID: 10202601 Clinical Trial.

5

The PDQ-39 Spanish version: reliability and correlation with the short-form health survey (SF-36).

Martínez Martín P, Frades B, Jiménez Jiménez FJ, Pondal M, López Lozano JJ, Vela L, Vázquez A, del Val Fernández J, Diví M, Fabregat N, Tuldrá A, Crespo Maraver MC, Molinero LM. Martínez Martín P, et al. Neurologia. 1999 Apr;14(4):159-63. Neurologia. 1999. PMID: 10363490

6

Conversion to controlled-release levodopa/carbidopa treatment and quality of life as measured by the Nottingham Health Profile. The STAR Study Group.

Martínez-Martín P, Grandas F, Linazasoro G, Bravo JL. Martínez-Martín P, et al. Neurologia. 1999 Aug-Sep;14(7):338-43. Neurologia. 1999. PMID: 10570620 Clinical Trial.

7

Pallidotomy and quality of life in patients with Parkinson's disease: an early study.

Martínez-Martín P, Valldeoriola F, Molinuevo JL, Nobbe FA, Rumià J, Tolosa E. Martínez-Martín P, et al. Mov Disord. 2000 Jan;15(1):65-70. doi: 10.1002/1531-8257(200001)15:1<65::aid-mds1011>3.0.co;2-y. Mov Disord. 2000. PMID: 10634243

8

Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease.

Martínez-Martín P, Valldeoriola F, Tolosa E, Pilleri M, Molinuevo JL, Rumià J, Ferrer E. Martínez-Martín P, et al. Mov Disord. 2002 Mar;17(2):372-7. doi: 10.1002/mds.10044. Mov Disord. 2002. PMID: 11921126

9

[Health-related quality of life in multiple sclerosis].

Benito-León J, Martínez-Martín P. Benito-León J, et al. Neurologia. 2003 May;18(4):210-7. Neurologia. 2003. PMID: 12721866 Review. Spanish.

10

Patients', doctors', and caregivers' assessment of disability using the UPDRS-ADL section: are these ratings interchangeable?

Martínez-Martín P, Benito-León J, Alonso F, Catalán MJ, Pondal M, Tobías A, Zamarbide I. Martínez-Martín P, et al. Mov Disord. 2003 Sep;18(9):985-92. doi: 10.1002/mds.10479. Mov Disord. 2003. PMID: 14502665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

553 results

Search Page

Filters